Clin2
NCT07511582Possibly a fitRecruiting

Steroids for severe breathing problems in the ICU

SepsisAcute Respiratory Distress Syndrome

Treatments studied

Part of Infections, Lungs & breathing clinical trials.

This study tests whether a corticosteroid (a type of anti-inflammatory medicine) can help people with severe breathing problems or serious infections who have a specific 'hyperinflammatory' pattern. If you are in the ICU on a ventilator, this trial may be an option for you.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 2
Enrollment
150 people
Ages
18 years and older
Study type
Interventional

Who can take part

  • You are 18 years or older.
  • You have a severe breathing problem (ARDS) or a serious infection that affects your whole body (sepsis).
  • You are on a breathing machine (ventilator) in the intensive care unit (ICU).
  • Your doctor can start the study medicine within 3 days (72 hours) of your breathing problem starting.
  • You do not have certain conditions like recent heart surgery, long-term steroid use, or a weakened immune system.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT04280497Recruiting
Testing fast ways to tell steroid-resistant sepsis from sensitive

This trial studies a quick set of tests to figure out whether a person with severe infection (sepsis) will respond to corticosteroids like hydrocortisone. The goal is to guide treatment sooner and avoid ineffective care.

Garches, Hauts-de-Seine
NCT07199192Not yet recruiting· Phase 4
Steroids for severe lung infections in hospitalized adults

This study tests whether giving a standard steroid medication (a type of anti-inflammatory drug) helps people with severe breathing infections recover faster and breathe better. If you qualify, you would receive either the steroid or a placebo while you're in the hospital.

Minneapolis, Minnesota
NCT07357935Not yet recruiting· Phase 1/Phase 2
Personalized steroids for severe pneumonia breathing failure

This study tests whether giving a personalized dose of steroids (anti-inflammatory medicine) early can help people with severe pneumonia-related breathing failure recover faster. It compares different steroid doses based on your body's inflammation and immune response.

NCT07576660Recruiting· Phase 3
Dexamethasone for lung injury from sepsis

This trial tests whether the steroid dexamethasone can help people with sepsis who develop acute respiratory distress syndrome (ARDS), a severe lung injury. If you have an infection and need breathing support, this study may help find a better treatment.

Nanjing, Jiangsu
NCT07152587Not yet recruiting· Phase 2/Phase 3
Anti-inflammatory treatment for severe pneumonia in the ICU

This trial tests whether adding anti-inflammatory medicine (steroids) to usual care helps people with severe pneumonia recover faster. It only includes patients who are seriously ill in the ICU, and the goal is to find the best way to reduce lung inflammation and improve outcomes.

NCT07152600Not yet recruiting· Phase 3
Steroids for severe adenovirus pneumonia in the ICU

This trial tests whether steroids (corticosteroids) can help adults with severe pneumonia caused by adenovirus (a common virus) who are in the ICU. The goal is to see if steroids reduce inflammation and improve recovery.

Hear when a new Sepsis trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.